Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 659 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphoma				Phase IV				U2963n NCT00097565
	Prevention of Cyclophosphamide, Hydroxydaunorubicin (Adriamycin), Oncovin (Vincristine), Prednisone/Prednisolone (CHOP)-Induced Chronic Cardiotoxicity				Phase IV				OLSG-0401 NCT00162955
	Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-Grade Lymphoma in Adults				Phase IV				GMALL05 NCT00199082
	Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2)				Phase IV				CR005596 NCT00398749
	Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.				Phase IV				Hemato INCAN 01/2007 NCT00429065
	Oral Zinc Therapy for the Prevention of Mucositis				Phase IV				SHEBA-06-4196-MKM-CTIL NCT00449592
	Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)				Phase IV				2006-003750-23 LINFOTARGAM, NCT00466258
	German Multicenter Trial for the Treatment of Newly Diagnosed T-Lymphoblastic Lymphoma in Adults				Phase IV				GMALL04 NCT00199017
	Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors				Phase IV				2006-00055-18 NCT00415103
	Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer				Phase III, Phase II				RPCI-RP-9815 NCI-V99-1527, NCT00003816, RP 98-15


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute